AI assistant
Sending…
Inotiv, Inc. — Director's Dealing 2017
Mar 15, 2017
34595_dirs_2017-03-15_90c9da05-2e73-499a-92fa-bbc4b038c582.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2017-03-01
Reporting Person: Downing Philip A (VP, Preclinical Srvcs.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-01 | Common Stock | M | 10000 | $1.01 | Acquired | 17000 | Direct |
| 2017-03-01 | Common Stock | F | 6235 | $1.62 | Disposed | 10765 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-01 | Employee Stock Option (right to buy) | $1.01 | M | 10000 | Disposed | 2020-08-15 | Common Stock (10000) | Direct |
More from Inotiv, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 10
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19